These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30679649)

  • 1. Incorporation of ifosfamide into various essential oils -based nanoemulsions ameliorates its apoptotic effect in the cancers cells.
    Alkhatib MH; AlMotwaa SM; Alkreathy HM
    Sci Rep; 2019 Jan; 9(1):695. PubMed ID: 30679649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity and apoptosis enhancement in breast and cervical cancer cells upon coadministration of mitomycin C and essential oils in nanoemulsion formulations.
    Al-Otaibi WA; Alkhatib MH; Wali AN
    Biomed Pharmacother; 2018 Oct; 106():946-955. PubMed ID: 30119267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineoplastic activity of mitomycin C formulated in nanoemulsions-based essential oils on HeLa cervical cancer cells.
    Alkhatib MH; Al-Otaibi WA; Wali AN
    Chem Biol Interact; 2018 Aug; 291():72-80. PubMed ID: 29908166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of ifosfamide to chloroacetaldehyde contributes to antitumor activity in vivo.
    Börner K; Kisro J; Brüggemann SK; Hagenah W; Peters SO; Wagner T
    Drug Metab Dispos; 2000 May; 28(5):573-6. PubMed ID: 10772637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating ifosfamide into salvia oil-based nanoemulsion diminishes its nephrotoxicity in mice inoculated with tumor.
    AlMotwaa SM; Alkhatib MH; Alkreathy HM
    Bioimpacts; 2020; 10(1):9-16. PubMed ID: 31988852
    [No Abstract]   [Full Text] [Related]  

  • 6. Ifosfamide cytotoxicity on human tumor and renal cells: role of chloroacetaldehyde in comparison to 4-hydroxyifosfamide.
    Brüggemann SK; Kisro J; Wagner T
    Cancer Res; 1997 Jul; 57(13):2676-80. PubMed ID: 9205076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The enhanced inhibitory effect of different antitumor agents in self-microemulsifying drug delivery systems on human cervical cancer HeLa cells.
    Ujhelyi Z; Kalantari A; Vecsernyés M; Róka E; Fenyvesi F; Póka R; Kozma B; Bácskay I
    Molecules; 2015 Jul; 20(7):13226-39. PubMed ID: 26197311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly-isoprenylated ifosfamide analogs: Preactivated antitumor agents as free formulation or nanoassemblies.
    Skarbek C; Delahousse J; Pioche-Durieu C; Baconnais S; Deroussent A; Renevret P; Rivard M; Desmaele D; Martens T; Le Cam E; Couvreur P; Paci A
    Int J Pharm; 2017 Nov; 532(2):748-756. PubMed ID: 28546071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer.
    Willits I; Price L; Parry A; Tilby MJ; Ford D; Cholerton S; Pearson AD; Boddy AV
    Br J Cancer; 2005 May; 92(9):1626-35. PubMed ID: 15827549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene.
    Chen L; Waxman DJ; Chen D; Kufe DW
    Cancer Res; 1996 Mar; 56(6):1331-40. PubMed ID: 8640822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell toxicity of oxazaphosphorine metabolites in comparison to their antileukemic activity.
    Brueggemann SK; Schlenke P; Klich S; Deeken M; Peters SO; Wagner T
    Biochem Pharmacol; 2002 Apr; 63(7):1337-41. PubMed ID: 11960610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells.
    Patzer L; Hernando N; Ziegler U; Beck-Schimmer B; Biber J; Murer H
    Kidney Int; 2006 Nov; 70(10):1725-34. PubMed ID: 17003823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical composition and cytotoxic properties of Clinacanthus nutans root extracts.
    Teoh PL; Cheng AY; Liau M; Lem FF; Kaling GP; Chua FN; Cheong BE
    Pharm Biol; 2017 Dec; 55(1):394-401. PubMed ID: 27931178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion kinetics of ifosfamide side-chain metabolites in children on continuous and short-term infusion.
    Silies H; Blaschke G; Hohenlöchter B; Rossi R; Jürgens H; Boos J
    Int J Clin Pharmacol Ther; 1998 May; 36(5):246-52. PubMed ID: 9629987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined 4-hydroxy-ifosfamide and vinorelbine treatment in established and primary human breast cell cultures.
    Ricotti L; Barzanti F; Tesei A; Amadori D; Gasperi-Campani A; Frassineti GL; Zoli W
    Ann Oncol; 2000 May; 11(5):587-94. PubMed ID: 10907953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of tumor-specific caffeine-potentiated chemotherapy using a novel drug delivery system with Span 80 nano-vesicles.
    Nakata H; Miyazaki T; Iwasaki T; Nakamura A; Kidani T; Sakayama K; Masumoto J; Miura H
    Oncol Rep; 2015 Apr; 33(4):1593-8. PubMed ID: 25633802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of the Chemical Composition and In Vitro Cytotoxic Mechanisms of Pallines Spinosa Flower and Leaf Essential Oils Against Breast Cancer Cells.
    Saleh AM; Al-Qudah MA; Nasr A; Rizvi SA; Borai A; Daghistani M
    Cell Physiol Biochem; 2017; 42(5):2043-2065. PubMed ID: 28803233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
    Knouzy B; Dubourg L; Baverel G; Michoudet C
    J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol improves ifosfamide-induced Fanconi syndrome in rats.
    Sehirli O; Sakarcan A; Velioğlu-Oğünç A; Cetinel S; Gedik N; Yeğen BC; Sener G
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):33-41. PubMed ID: 17481685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice.
    Badary OA
    J Ethnopharmacol; 1999 Nov; 67(2):135-42. PubMed ID: 10619376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.